The Aword

  • Increase font size
  • Default font size
  • Decrease font size


E-mail Print PDF


In 1964, Hagan of the Division of Toxicological Evaluation (DTE) branch of the FDA reviewed the animal toxicity data for Pantopaque that had been submitted with NDA 5-319 (the original NDA for Pantopaque).


He expressed major concerns about the pyrogenicity of the product and suggested a repeat dose after a ten-day interval to investigate further.


This was not apparently ever carried out.